Dr. Martens (LON:DOCS) Insider Giles Wilson Acquires 176 Shares

Dr. Martens plc (LON:DOCS) insider Giles Wilson purchased 176 shares of Dr. Martens stock in a transaction dated Tuesday, November 11th. The shares were acquired at an average cost of GBX 85 per share, for a total transaction of £149.60.

Giles Wilson also recently made the following trade(s):

• On Monday, October 13th, Giles Wilson acquired 167 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 89 per share, with a total value of £148.63.
• On Wednesday, October 8th, Giles Wilson bought 114 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 90 per share, for a total transaction of £102.60.
• On Thursday, September 11th, Giles Wilson bought 167 shares of Dr. Martens stock. The shares were acquired at an average cost of GBX 90 per share, for a total transaction of £150.30.
• On Monday, September 1st, Giles Wilson purchased 105,838 shares of Dr. Martens stock. The stock was acquired at an average price of GBX 91 per share, with a total value of £96,312.58.
• On Monday, September 1st, Giles Wilson sold 30,000 shares of Dr. Martens stock. The stock was sold at an average price of GBX 91, for a total value of £27,300.
• On Monday, September 1st, Giles Wilson purchased 30,019 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 91 per share, for a total transaction of £27,317.29.
• On Monday, September 1st, Giles Wilson sold 105,785 shares of Dr. Martens stock. The shares were sold at an average price of GBX 90, for a total transaction of £95,206.50.

Dr. Martens Stock Performance

Shares of Dr. Martens stock opened at GBX 86.40 on Thursday. The company has a 50 day moving average price of GBX 91.29 and a 200 day moving average price of GBX 79.33. The firm has a market capitalization of £834.91 million, a P/E ratio of 172.80, a PEG ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. Dr. Martens plc has a 52 week low of GBX 43.02 and a 52 week high of GBX 100.87.

Wall Street Analysts Forecast Growth

Separately, Peel Hunt upgraded shares of Dr. Martens to a “buy” rating in a research note on Monday, August 18th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of GBX 6,000.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.